• AML
  • Qui Tam
  • SEC
  • CFTC
  • FCPA
  • FAQS
Demand Protections for Artificial Intelligence Whistleblowers | Take Action!
Subscribe
Donate
Get Help
No Result
View All Result
Whistleblower Network News
The Truth at Any Cost.
Qui Tam, Compliance and Anti-Corruption News.
Whistleblower Network News
No Result
View All Result
Home False Claims-Qui Tam

DOJ Joins Qui Tam Lawsuit Against CVS for Violating Controlled Substances Act and False Claims Act Amid Opioid Crisis

Melissa RevueltabyMelissa Revuelta
December 23, 2024
in False Claims-Qui Tam
Reading Time: 3 mins read
CVS Whistleblower
Share on TwitterShare on FacebookShare on LinkedInEmail

On December 18, the Department of Justice (DOJ) announced that it is filing a lawsuit against CVS Pharmacy Inc. and its various subsidiaries for knowingly dispensing controlled substances in violation of the Controlled Substances Act (CSA) and the False Claims Act (FCA). CVS is currently the largest pharmacy chain in the United States, with more than 9,000 locations nationwide. 

The government alleges that from October 17, 2013, to the present, “CVS knowingly filled prescriptions for controlled substances that lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice.” Furthermore, the government claims that by “knowingly filling unlawful prescriptions for controlled substances, CVS violated the Controlled Substances Act and, where CVS sought reimbursement from federal healthcare programs, also violated the False Claims Act.”

The complaint also asserts that CVS’s actions contributed to the opioid crisis, and in some tragic cases, patients overdosed and died shortly after filling unlawful prescriptions at CVS.

Register for National Whistleblower Day Register for National Whistleblower Day Register for National Whistleblower Day

“Opioid deaths remain a scourge on communities across Rhode Island and the nation, robbing families of loved ones and leaving a path of devastation in their wake,” said U.S. Attorney Zachary A. Cunha for the District of Rhode Island. “This lawsuit alleges that CVS failed to exercise its critical role as gatekeeper of dangerous prescription opioids and, instead, facilitated the illegal proliferation of these highly addictive drugs, including by pill mill prescribers. When corporations such as CVS prize profits over patient safety and overburden their pharmacy staff so that they cannot carry out the basic responsibility of ensuring that prescriptions are legitimate, we will use every tool at our disposal to see that they answer for it.”

This case arises from a whistleblower named Hillary Estright, who previously worked for CVS and filed the complaint under the qui tam provisions of the False Claims Act. Under the False Claims Act’s qui tam provisions, individuals may file lawsuits alleging government contracting fraud on behalf of the United States. In successful qui tam cases, whistleblowers are eligible to receive between 15 and 30% of the settlement or judgment. 

“Pharmacies and pharmacists are critical partners to ensure controlled substances are dispensed lawfully and safely to the public,” said Deputy Inspector General Christian J. Schrank of the Department of Health and Human Services Office of Inspector General (HHS-OIG). “HHS-OIG is committed to holding individuals and entities that dispense these controlled substances improperly and without legitimate medical purpose accountable.”

In July 2023, a bipartisan group of senators introduced the False Claims Amendments Act of 2023, which address a few technical loopholes undermining the success of the FCA. The bill is widely supported by whistleblower advocates.

National Whistleblower Center (NWC) has issued an Action Alert calling on Congress to pass the bill.

The claims asserted in this case are allegations only, and there has been no determination of liability.

Join NWC in Taking Action:

Demand that Congress strengthen the False Claims Act

Further Reading:

Justice Department Files Nationwide Lawsuit Alleging CVS Knowingly Dispensed Controlled Substances in Violation of the Controlled Substances Act and the False Claims Act

Bipartisan Legislation Unveiled to Strengthen False Claims Act

More False Claims Act Whistleblower News

Previous Post

Fired VinFast Whistleblower Filed Disclosures with SEC, NHTSA

Next Post

Blueprint for Free Speech Announces Whistleblowing Awards for 2024

Melissa Revuelta

Melissa Revuelta

Melissa is a senior law clerk at Kohn, Kohn & Colapinto, providing litigation and administrative support to the firm’s attorneys. She graduated from the University of California, Riverside, in June 2022, with a bachelor’s degree in Education, Society, and Human Development and a double major in Political Science. While in college, Melissa participated in AmeriCorps, tutoring children and leading community service events. At KKC, Melissa spearheaded pro-bono training modules in Mexico, forging partnerships between the National Whistleblower Center and Tec de Monterrey, the top private school in Mexico.

Next Post
Whistleblowing

Blueprint for Free Speech Announces Whistleblowing Awards for 2024

Receive Daily Alerts

Subscribe to receive daily breaking news and legislative developments sent to your inbox.

  • This field is for validation purposes and should be left unchanged.

Most Popular

Senator: AI Whistleblower Bill “Will Bring Transparency and Accountability to the AI Sector Before it’s Too Late”

Whistleblower Case Against Florida Ophthalmology Practice Results in $615K False Claims Act Settlement

Senators Grassley and Wyden to Speak at National Whistleblower Day Celebration

SEC Should Continue Strong Crypto Enforcement, Whistleblower Advocates Argue

Advocate Details Impact of Bipartisan AI Whistleblower Bill for Tech Works

CFTC Awards $700,000 to Whistleblower for “Courage” and “Critical Role in Enforcement Efforts”

Whistleblower Poll

Whistleblower Poll
Whistleblower Poll

Exclusive Marist Poll: Overwhelming Public Support Among Likely Voters For Increased Whistleblower Protections

byGeoff Schweller
October 6, 2020

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

STAY INFORMED.
Subscribe to receive breaking whistleblower updates.

  • This field is for validation purposes and should be left unchanged.

About Us

  • About
  • Contact Us
  • Donate
  • Careers

Subscribe

  • Daily Mail
  • Follow us on Twitter
  • YouTube Channel

Contribute

  • Letter to the Editor
  • Submission Guidelines
  • Reprint Guidelines

Your Experience

  • Accessibility Statement
  • Privacy Policy
  • Terms of Use

Help

  • Rules for Whistleblowers
  • Frequently Asked Questions
  • Advertise
Whistleblower Network News

Whistleblower Network News is an independent online newspaper providing our readers with up-to-date information on whistleblowing. Our goal is to be the best source of information on important qui tam, anti-corruption, compliance, and whistleblower law developments.

Submit an Article

Copyright © 2025, Whistleblower Network News. All Rights Reserved.

This Newspaper/Web Site is made available by the publisher for educational purposes only as well as to give you general information and a general understanding of the law, not to provide specific legal advice. By using this website, you understand that there is no attorney-client relationship between you and the Newspaper/Web Site publisher. The Newspaper/Web Site should not be used as a substitute for competent legal advice from a licensed professional attorney in your state.

Become a Whistleblower Network News Subscriber

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Subscribe to WNN

Retrieve your password

Please enter your username or email address to reset your password.

Subscribe to WNN
Join the Waitlist for National Whistleblower Day 2025! July 30, 2025 on Capitol Hill
JOIN WAITLIST

Add New Playlist

Demand Protections for Artificial Intelligence Whistleblowers

Take Action!
No Result
View All Result
  • Exclusives
  • Government
    • False Claims-Qui Tam
    • Federal Employees
    • Intelligence
  • Corporate
    • CFTC & Commodities
    • Dodd-Frank
    • IRS & Tax
    • SEC & Securities
  • Features
  • Legislation
  • International
    • Foreign Corruption
  • Rewards
  • Whistleblower of the Week
  • Environment & Climate
  • Opinion
  • Editorial
  • Employment
    • Sarbanes-Oxley Whistleblowers
    • Retaliation
    • OSHA
  • Make National Whistleblower Day Permanent
  • Media
    • Podcasts
    • Videos
    • Webinars
    • National Whistleblower Day
  • Whistleblower Poll
  • Whistleblower Resources
    • Frequently Asked Questions
    • Resources for Locating An Attorney
    • The New Whistleblowers Handbook

Copyright © 2024, Whistleblower Network News. All Rights Reserved.

Go to mobile version